Jilin Fukang Pharmaceutical

Jilin Fukang Pharmaceutical is a China-based pharmaceutical manufacturer focused on finished-dose medicines, traditional Chinese medicine products, decoction pieces, and health foods. The company operates as an integrated research, development, manufacturing, sales, and service enterprise, with production capabilities spanning capsules, tablets, granules, herbal decoction pieces, and pre-processing/extraction. Its disclosed commercial portfolio includes a range of Chinese patent medicines such as pudilan anti-inflammatory tablets, tongqiao biyan tablets, weikangling capsules, compound houttuynia tablets, and several other oral solid products, alongside proprietary health food products. The company is listed on China’s National Equities Exchange and Quotations system and appears to be commercially oriented rather than a clinical-stage biotech developer. Public disclosures also indicate ongoing product-license transfers and supplemental approvals for additional marketed traditional medicine products.